华海药业(600521)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600521 华海药业

已收盘 07-29 15:00:00

{"stockData":{"symbol":"600521","market":"SH","secType":"STK","nameCN":"华海药业","latestPrice":23.05,"timestamp":1753772400000,"preClose":22.2,"halted":0,"volume":58619661,"delay":0,"changeRate":0.0383,"floatShares":1456000000,"shares":1497000000,"eps":0.7651,"marketStatus":"已收盘","change":0.85,"latestTime":"07-29 15:00:00","open":22.18,"high":23.32,"low":21.53,"amount":1326000000,"amplitude":0.0806,"askPrice":23.06,"askSize":218,"bidPrice":23.05,"bidSize":938,"shortable":0,"etf":0,"ttmEps":0.7651,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753839000000},"marketStatusCode":5,"adr":0,"adjPreClose":22.2,"symbolType":"stock","openAndCloseTimeList":[[1753752600000,1753759800000],[1753765200000,1753772400000]],"highLimit":24.42,"lowLimit":19.98,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1497251081,"isCdr":false,"pbRate":3.62,"roa":"--","peRate":30.126781,"roe":"3.29%","epsLYR":0.77,"committee":0.387815,"marketValue":34512000000,"turnoverRate":0.0403,"status":0,"floatMarketCap":33563000000},"requestUrl":"/m/hq/s/600521","defaultTab":"news","newsList":[{"id":"2555443080","title":"华海药业股价大涨5.11% 股价创9个月以来新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2555443080","media":"中国财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555443080?lang=zh_cn&edition=full","pubTime":"2025-07-29 15:04","pubTimestamp":1753772653,"startTime":"0","endTime":"0","summary":"中国财富网智讯 01月10日13时41分，华海药业 出现异动，股价大涨，股价创9个月以来新高。市场表现走势弱于大盘，弱于行业。机构评级最近3个月内，共有9家机构发布评级，整体评级为增持。成长分析2021年前三季度营收45.98亿元, 同比增长-5.60%，2021年前三季度净利5.90亿元, 同比增长-29.85%，市盈率44.50。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729150735a6c74989&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729150735a6c74989&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0188","BK0028","BK0012","BK0070","BK0201","600521","BK0185"],"gpt_icon":0},{"id":"2554737467","title":"高血压概念盘中跳水，华海药业跌0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554737467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554737467?lang=zh_cn&edition=full","pubTime":"2025-07-25 10:11","pubTimestamp":1753409519,"startTime":"0","endTime":"0","summary":"07月25日，高血压概念盘中跳水，截至10点11分，高血压概念整体指数下跌0.51%，报1631.590点。从个股上来看，该概念的成分股中，华海药业跌0.14%，润都股份跌幅居前。从资金上来看，截止发稿，高血压概念主力净流入为-9069.86万，其中乐心医疗受到资金热捧，主力净流入2023.85万；拉长时间线来看，该板块近20日主力资金净流入7.74亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072510115994b97b15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072510115994b97b15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0201","BK0028","600521","BK0239","BK0185","BK0188","BK0070"],"gpt_icon":0},{"id":"2554734415","title":"单抗概念盘中拉升，誉衡药业涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2554734415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554734415?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:37","pubTimestamp":1753407453,"startTime":"0","endTime":"0","summary":"07月25日，单抗概念盘中拉升，截至09点37分，单抗概念整体指数上涨0.66%，报2690.320点。从个股上来看，该概念的成分股中，誉衡药业涨停，百济神州-U、华海药业、华东医药涨幅居前。从资金上来看，截止发稿，单抗概念概念主力净流入为-4863.45万，其中誉衡药业受到资金热捧，主力净流入1.18亿；拉长时间线来看，该板块近20日主力资金净流入-4.73亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725093733971d2e99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725093733971d2e99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0201","BK0070","BK0185","BK0188","BK0239","688235","BK0060","BK0028","600521","BK0077","002437","BK0095"],"gpt_icon":0},{"id":"2553206936","title":"华海药业：募投项目结项并将节余募集资金永久补充流动资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2553206936","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553206936?lang=zh_cn&edition=full","pubTime":"2025-07-24 17:55","pubTimestamp":1753350958,"startTime":"0","endTime":"0","summary":"格隆汇7月24日丨华海药业(600521.SH)公布，鉴于“浙江华海生物科技有限公司ADC产业化技改项目”已建成，募集资金专用账户的实际节余资金总额为963.07万元（含利息收入）。为有效发挥募集资金的使用效益，公司将前述节余资金以及后续募集资金专户注销前产生的利息收入与手续费差额所形成的节余款（实际金额以资金转出当日募集资金专用账户余额为准），永久性补充流动资金，用于公司日常生产经营。本次节余募集资金永久补充流动资金后，公司仍将保留募集资金专户，直至所有待支付合同款项支付完毕。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072417560594b80410&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072417560594b80410&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600521","BK0239","BK0188","BK0201","BK0070","BK0028","BK0012","BK0185"],"gpt_icon":0},{"id":"2553267515","title":"高血压概念盘中拉升，一品红涨1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553267515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553267515?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:40","pubTimestamp":1753234847,"startTime":"0","endTime":"0","summary":"07月23日，高血压概念盘中拉升，截至09点40分，高血压概念整体指数上涨0.58%，报1578.240点。从个股上来看，该概念的成分股中，一品红涨1.13%，天宇股份、华海药业、普洛药业涨幅居前。从资金上来看，截止发稿，高血压概念主力净流入为-4988.57万，其中一品红受到资金热捧，主力净流入1193.47万；拉长时间线来看，该板块近20日主力资金净流入5.02亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094047954dd24e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094047954dd24e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0201","BK0070","300723","BK0185","BK0188","BK0239","BK0028","600521"],"gpt_icon":0},{"id":"2553226751","title":"单抗概念盘中拉升，百济神州-U涨0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553226751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553226751?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:39","pubTimestamp":1753234793,"startTime":"0","endTime":"0","summary":"07月23日，单抗概念盘中拉升，截至09点39分，单抗概念整体指数上涨0.66%，报2657.650点。从个股上来看，该概念的成分股中，百济神州-U涨0.48%，上海医药、国药一致、华海药业涨幅居前。从资金上来看，截止发稿，单抗概念概念主力净流入为-1.40亿，其中苑东生物受到资金热捧，主力净流入348.54万；拉长时间线来看，该板块近20日主力资金净流入5384.79万。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723093953954dd1c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723093953954dd1c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0201","BK0185","688235","BK0188","BK0028","BK0070","BK0239","600521","688513"],"gpt_icon":0},{"id":"2552490487","title":"华海药业公布国际专利申请：“一种乌帕替尼或其水合物的合成工艺”","url":"https://stock-news.laohu8.com/highlight/detail?id=2552490487","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552490487?lang=zh_cn&edition=full","pubTime":"2025-07-19 04:52","pubTimestamp":1752871945,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示华海药业（600521）公布了一项国际专利申请，专利名为“一种乌帕替尼或其水合物的合成工艺”，专利申请号为PCT/CN2025/071650，国际公布日为2025年7月17日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来华海药业已公布的国际专利申请7个，较去年同期增加了16.67%。结合公司2024年年报财务数据，2024年公司在研发方面投入了9.87亿元，同比增0.38%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071900003413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","600521","BK0070","BK0028","BK0188","BK0239","BK0185","BK0012"],"gpt_icon":0},{"id":"2552724430","title":"高盛做空华海药业：业绩腰斩、蹭热点难掩管线BD困局","url":"https://stock-news.laohu8.com/highlight/detail?id=2552724430","media":"市值财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552724430?lang=zh_cn&edition=full","pubTime":"2025-07-17 15:27","pubTimestamp":1752737243,"startTime":"0","endTime":"0","summary":"7月14日，华海药业发布2025年上半年业绩预警：预计净利润3.74亿至4.49亿元，同比骤降40%-50%，低于市场预期。外资的做空逻辑，高估值与业绩背离外资机构在最新研报中强调，华海药业当前市盈率已显著高于五年均值，估值明显偏离基本面。此前，2025年6月9日，华海药业收到FDA针对浙江临海汛桥生产基地的警告信，直指口服固体设备清洁管理、无菌区域维护等严重缺陷。而这并非华海首次遭遇海外监管重击。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717154141a450765f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717154141a450765f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0201","BK0185","BK0188","600521","BK0012","BK0028","BK0239","BK0070"],"gpt_icon":0},{"id":"2552764241","title":"专项行动赋能创新 台州医药产业“链上开花”","url":"https://stock-news.laohu8.com/highlight/detail?id=2552764241","media":"潮新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552764241?lang=zh_cn&edition=full","pubTime":"2025-07-17 08:07","pubTimestamp":1752710876,"startTime":"0","endTime":"0","summary":"034月1日，全省院士之家服务创新浙江专项行动启动仪式在台州举办，华海药业等4家台州企业与院士团队签约4项成果转化项目，加速科研成果从“实验室”走向“生产线”，推动产学研用协同创新。作为全国医药健康产业重镇，台州市科协积极响应，迅速将专项行动纳入“三大牵引性抓手攻坚年活动”整体框架，推动创新资源向产业一线集聚。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071708101297a9020a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071708101297a9020a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0201","BK0012","BK0028","BK0070","600521","BK0188","BK0185","600267","BK0239"],"gpt_icon":0},{"id":"2551117165","title":"单抗概念盘中拉升，丽珠集团涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2551117165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551117165?lang=zh_cn&edition=full","pubTime":"2025-07-16 14:19","pubTimestamp":1752646793,"startTime":"0","endTime":"0","summary":"07月16日，单抗概念盘中拉升，截至14点19分，单抗概念整体指数上涨2.00%，报2550.550点。从个股上来看，该概念的成分股中，丽珠集团涨停，奥赛康、健康元2只股涨幅超过5%。从资金上来看，截止发稿，单抗概念概念主力净流入为4.90亿，其中华海药业受到资金热捧，主力净流入1.08亿；拉长时间线来看，该板块近20日主力资金净流入6.59亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716141953a44df76c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716141953a44df76c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0114","600521","BK0077","BK0239","BK0187","BK0046","BK0188","000513","BK0028","600380"],"gpt_icon":0},{"id":"2551112821","title":"2025年医药市场现状与竞争格局解析：支付改革推动创新药放量提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2551112821","media":"报告大厅","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551112821?lang=zh_cn&edition=full","pubTime":"2025-07-16 11:30","pubTimestamp":1752636616,"startTime":"0","endTime":"0","summary":"2025年医药行业在支付端改革、技术创新出海及刚性需求支撑下呈现结构性繁荣。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507161146409544544e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507161146409544544e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","603087","603858","BK0060","BK0188","BK0239","600521","159992","600329","159938","BK0164"],"gpt_icon":0},{"id":"2551119694","title":"华海药业涨5.11% 政策利好与资金流入推动股价反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=2551119694","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551119694?lang=zh_cn&edition=full","pubTime":"2025-07-16 11:00","pubTimestamp":1752634859,"startTime":"0","endTime":"0","summary":"华海药业股价今日大幅上涨，截至11点00分，最新价为22.02元/股，涨幅达5.11%。政策驱动与资金面共振近期华海药业股价波动与政策面及资金流向密切相关。7月1日创新药支持政策落地后，主力资金三日内涌入5.61亿元推升股价突破19元关口。叠加7月16日化学制药板块上涨1.10%，资金面与板块效应共同催化股价反弹。成长性与业绩压力交织长期来看，华海药业的核心逻辑在于全球化布局与创新药研发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716110109a44da496&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716110109a44da496&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0201","BK0012","BK0185","BK0188","BK0028","600521","BK0239"],"gpt_icon":0},{"id":"2551072116","title":"高血压概念盘中拉升，润都股份涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2551072116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551072116?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:49","pubTimestamp":1752630597,"startTime":"0","endTime":"0","summary":"07月16日，高血压概念盘中拉升，截至09点49分，高血压概念整体指数上涨1.02%，报1489.710点。从个股上来看，该概念的成分股中，润都股份涨停，信立泰、华海药业、立方制药涨幅居前。从资金上来看，截止发稿，高血压概念主力净流入为1.07亿，其中恒瑞医药受到资金热捧，主力净流入3436.96万；拉长时间线来看，该板块近20日主力资金净流入4.11亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716094957a44d7e17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716094957a44d7e17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0028","BK0070","BK0185","600276","BK0239","BK0012","600521","BK0201","002923"],"gpt_icon":0},{"id":"2551115542","title":"超级真菌概念盘中跳水，东北制药平盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2551115542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551115542?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:36","pubTimestamp":1752629786,"startTime":"0","endTime":"0","summary":"07月16日，超级真菌概念盘中跳水，截至09点36分，超级真菌概念整体指数下跌0.71%，报804.630点。从个股上来看，该概念的成分股中，东北制药平盘，华神科技跌幅居前。从资金上来看，截止发稿，超级真菌概念主力净流入为-251.00万，其中华海药业受到资金热捧，主力净流入880.56万；拉长时间线来看，该板块近20日主力资金净流入-11.31亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093626a44d7546&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093626a44d7546&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0201","BK0012","BK0191","BK0028","BK0070","BK0188","000597","BK0185","600521","BK0239"],"gpt_icon":0},{"id":"2551697010","title":"细胞免疫治疗概念盘中拉升，近岸蛋白涨8.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551697010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551697010?lang=zh_cn&edition=full","pubTime":"2025-07-14 14:56","pubTimestamp":1752476216,"startTime":"0","endTime":"0","summary":"07月14日，细胞免疫治疗概念盘中拉升，截至14点56分，细胞免疫治疗概念整体指数上涨1.03%，报958.390点。从个股上来看，该概念的成分股中，近岸蛋白涨8.21%，冠昊生物、泰林生物等3只股涨幅超过5%。从资金上来看，截止发稿，细胞免疫治疗概念主力净流入为-2.09亿，其中华海药业受到资金热捧，主力净流入8537.59万；拉长时间线来看，该板块近20日主力资金净流入-38.85亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714145656a6a803fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714145656a6a803fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0185","BK0188","BK0028","688137","BK0239","BK0070","BK0012","BK0201","BK0216","600521"],"gpt_icon":0},{"id":"2550798721","title":"华海药业：获得琥珀酸美托洛尔缓释片和盐酸尼卡地平注射液的药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2550798721","media":"蓝鲸财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550798721?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:30","pubTimestamp":1752222605,"startTime":"0","endTime":"0","summary":"蓝鲸新闻7月11日电，华海药业(600521.SH)公告称，公司收到国家药品监督管理局核准签发的琥珀酸美托洛尔缓释片和盐酸尼卡地平注射液的《药品注册证书》。琥珀酸美托洛尔缓释片用于治疗高血压、心绞痛等，2024年国内市场销售金额约30.66亿元；盐酸尼卡地平注射液适用于手术时异常高血压的紧急处理和高血压急症，2024年国内市场销售金额约6.32亿元。这两个产品按化学药品4类批准生产可视同通过一致性评价，将丰富公司产品线，提升市场竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711163150953e8420&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711163150953e8420&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600521","BK0188","BK0239","BK0185","BK0012","BK0028","BK0201","BK0070"],"gpt_icon":0},{"id":"2550516981","title":"华海药业：生物创新药板块专注肿瘤和自身免疫疾病领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2550516981","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550516981?lang=zh_cn&edition=full","pubTime":"2025-07-11 15:33","pubTimestamp":1752219196,"startTime":"0","endTime":"0","summary":"证券之星消息，华海药业07月11日在投资者关系平台上答复投资者关心的问题。公司始终秉承着创新驱动发展的战略，推进创新药物研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100019403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600521","BK0012","BK1161","BK0185","BK0201","BK0188","06978","BK0239","BK0028","BK1574","BK0070","159992"],"gpt_icon":0},{"id":"2550864699","title":"研报掘金丨西部证券：首予华海药业“增持”评级，生物新药在研管线快速推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2550864699","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550864699?lang=zh_cn&edition=full","pubTime":"2025-07-10 17:39","pubTimestamp":1752140382,"startTime":"0","endTime":"0","summary":"西部证券研报指出，原料药基石业务稳健，华海药业新业务开拓进展顺利。公司是国内特色原料药龙头企业之一，全球沙坦类、普利类原料药主要供应商，近年来中枢神经类原料药产品收入快速增长，同时抗感染、消化、呼吸等新品逐步上量，形成丰富产品梯队。目前沙坦、普利类原料药价格趋稳，同时公司新业务开拓进展顺利，2024年公司新增合作客户150余家，新上市产品50余个，完成210余个新增供应商验证项目，为公司原料药业务注入增长新动能。基于公司原料药业务稳健增长，制剂全球化布局，生物新药在研管线快速推进，首次覆盖给予“增持”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071017400397a0c9eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071017400397a0c9eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600521","002673"],"gpt_icon":0},{"id":"2550175656","title":"市场近8年最低！国采盯上9个高血压药，39亿大品种遭“哄抢”，倍特、苑东蓄势待发","url":"https://stock-news.laohu8.com/highlight/detail?id=2550175656","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550175656?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:31","pubTimestamp":1752136284,"startTime":"0","endTime":"0","summary":"日前流出的拟采购药品清单征求意见稿中，有2个高血压药在列，39亿大品种遭“哄抢”。此外，7个高血压药未被纳入但已满足国采入围门槛。受集采影响，近年来高血压化药在中国公立医疗机构终端销售额持续下跌，2024年创近8年新低；TOP20产品中，“一哥”易主，这款国产新药亮了。市场创近8年最低！国采盯上9个品种截至7月9日，112个高血压化药已有企业过评或视同过评。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710164745a4422a81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710164745a4422a81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1570","600521","600196","03320"],"gpt_icon":0},{"id":"2550469968","title":"华海药业：医药制造领先企业 创新研发开启发展新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=2550469968","media":"西部证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550469968?lang=zh_cn&edition=full","pubTime":"2025-07-10 07:17","pubTimestamp":1752103020,"startTime":"0","endTime":"0","summary":"公司是国内特色原料药龙头企业之一，全球沙坦类、普利类原料药主要供应商，近年来中枢神经类原料药产品收入快速增长，同时抗感染、消化、呼吸等新品逐步上量，形成丰富产品梯队。目前沙坦、普利类原料药价格趋稳，同时公司新业务开拓进展顺利，2024 年公司新增合作客户150 余家，新上市产品50 余个，完成210 余个新增供应商验证项目，为公司原料药业务注入增长新动能。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710103117a4417ebd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710103117a4417ebd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0070","BK0188","BK0028","BK0201","159938","BK0185","600521","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753802029629,"stockEarnings":[{"period":"1week","weight":0.0114},{"period":"1month","weight":0.2051},{"period":"3month","weight":0.5622},{"period":"6month","weight":0.4483},{"period":"1year","weight":0.35},{"period":"ytd","weight":0.2571}],"compareEarnings":[{"period":"1week","weight":0.0107},{"period":"1month","weight":0.0507},{"period":"3month","weight":0.0947},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2446},{"period":"ytd","weight":0.0734}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江华海药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"62676人(较上一季度增加22.34%)","perCapita":"23232股","listingDate":"2003-03-04","address":"浙江省台州市临海市汛桥","registeredCapital":"149725万元","survey":"　　浙江华海药业股份有限公司主营业务为多剂型的仿制药、生物药、创新药及特色原料药的研发、生产和销售。公司的主要产品有心血管类、精神障碍类、神经系统类、抗感染类等为主导的产品系列。2023年4月，公司荣获“全国五一劳动奖状”和“浙江省五一劳动奖状”，同月，公司被浙江省药品检查中心认定为浙江省职业检查“尖兵领航”工程实训基地；2023年6月，公司入选米内网颁发的2022年度中国化药企业百强等。","listedPrice":15.55},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华海药业(600521)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华海药业(600521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华海药业,600521,华海药业股票,华海药业股票老虎,华海药业股票老虎国际,华海药业行情,华海药业股票行情,华海药业股价,华海药业股市,华海药业股票价格,华海药业股票交易,华海药业股票购买,华海药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华海药业(600521)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华海药业(600521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}